Literature DB >> 35705493

The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders.

Lili Zhang1, Xiangyun Wei2.   

Abstract

Normal neural circuits and functions depend on proper neuronal differentiation, migration, synaptic plasticity, and maintenance. Abnormalities in these processes underlie various neurodevelopmental, neuropsychiatric, and neurodegenerative disorders. Neural development and maintenance are regulated by many proteins. Among them are Par3, Par6 (partitioning defective 3 and 6), and aPKC (atypical protein kinase C) families of evolutionarily conserved polarity proteins. These proteins perform versatile functions by forming tripartite or other combinations of protein complexes, which hereafter are collectively referred to as "Par complexes." In this review, we summarize the major findings on their biophysical and biochemical properties in cell polarization and signaling pathways. We next summarize their expression and localization in the nervous system as well as their versatile functions in various aspects of neurodevelopment, including neuroepithelial polarity, neurogenesis, neuronal migration, neurite differentiation, synaptic plasticity, and memory. These versatile functions rely on the fundamental roles of Par complexes in cell polarity in distinct cellular contexts. We also discuss how cell polarization may correlate with subcellular polarization in neurons. Finally, we review the involvement of Par complexes in neuropsychiatric and neurodegenerative disorders, such as schizophrenia and Alzheimer's disease. While emerging evidence indicates that Par complexes are essential for proper neural development and maintenance, many questions on their in vivo functions have yet to be answered. Thus, Par3, Par6, and aPKC continue to be important research topics to advance neuroscience.
Copyright © 2022 the authors.

Entities:  

Keywords:  Alzheimer's disease; Par3; Par6; aPKC; cell polarity; neuropsychiatric disorder

Mesh:

Substances:

Year:  2022        PMID: 35705493      PMCID: PMC9188383          DOI: 10.1523/JNEUROSCI.0059-22.2022

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.709


  310 in total

1.  Rare Deleterious PARD3 Variants in the aPKC-Binding Region are Implicated in the Pathogenesis of Human Cranial Neural Tube Defects Via Disrupting Apical Tight Junction Formation.

Authors:  Xiaoli Chen; Yu An; Yonghui Gao; Liu Guo; Lei Rui; Hua Xie; Mei Sun; Siv Lam Hung; Xiaoming Sheng; Jizhen Zou; Yihua Bao; Hongyan Guan; Bo Niu; Zandong Li; Richard H Finnell; James F Gusella; Bai-Lin Wu; Ting Zhang
Journal:  Hum Mutat       Date:  2017-02-15       Impact factor: 4.878

2.  Structural insights into the intrinsic self-assembly of Par-3 N-terminal domain.

Authors:  Yan Zhang; Wenjuan Wang; Jia Chen; Kai Zhang; Feng Gao; Bingquan Gao; Shuai Zhang; Mingdong Dong; Flemming Besenbacher; Weimin Gong; Mingjie Zhang; Fei Sun; Wei Feng
Journal:  Structure       Date:  2013-05-02       Impact factor: 5.006

3.  PAR-6-PAR-3 mediates Cdc42-induced Rac activation through the Rac GEFs STEF/Tiam1.

Authors:  Takashi Nishimura; Tomoya Yamaguchi; Katsuhiro Kato; Masato Yoshizawa; Yo-ichi Nabeshima; Shigeo Ohno; Mikio Hoshino; Kozo Kaibuchi
Journal:  Nat Cell Biol       Date:  2005-02-20       Impact factor: 28.824

4.  Distinct Roles of PKCι/λ and PKMζ in the Initiation and Maintenance of Hippocampal Long-Term Potentiation and Memory.

Authors:  Shaoli Wang; Tao Sheng; Siqiang Ren; Tian Tian; Wei Lu
Journal:  Cell Rep       Date:  2016-08-04       Impact factor: 9.423

5.  Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.

Authors:  Joseph L McClay; Daniel E Adkins; Karolina Aberg; Jozsef Bukszár; Amit N Khachane; Richard S E Keefe; Diana O Perkins; Joseph P McEvoy; T Scott Stroup; Robert E Vann; Patrick M Beardsley; Jeffrey A Lieberman; Patrick F Sullivan; Edwin J C G van den Oord
Journal:  Neuropsychopharmacology       Date:  2010-11-24       Impact factor: 7.853

6.  Genetic analysis of Alzheimer's disease in the Uppsala Longitudinal Study of Adult Men.

Authors:  Vilmantas Giedraitis; Lena Kilander; Malin Degerman-Gunnarsson; Johan Sundelöf; Tomas Axelsson; Ann-Christine Syvänen; Lars Lannfelt; Anna Glaser
Journal:  Dement Geriatr Cogn Disord       Date:  2009-01-14       Impact factor: 2.959

7.  KIBRA Co-localizes with protein kinase Mzeta (PKMzeta) in the mouse hippocampus.

Authors:  Yohei Yoshihama; Takaaki Hirai; Takashi Ohtsuka; Kazuhiro Chida
Journal:  Biosci Biotechnol Biochem       Date:  2009-01-07       Impact factor: 2.043

8.  PKM zeta restricts dendritic arbor growth by filopodial and branch stabilization within the intact and awake developing brain.

Authors:  Xue Feng Liu; Parisa Karimi Tari; Kurt Haas
Journal:  J Neurosci       Date:  2009-09-30       Impact factor: 6.167

9.  Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations.

Authors:  Brian J O'Roak; Laura Vives; Santhosh Girirajan; Emre Karakoc; Niklas Krumm; Bradley P Coe; Roie Levy; Arthur Ko; Choli Lee; Joshua D Smith; Emily H Turner; Ian B Stanaway; Benjamin Vernot; Maika Malig; Carl Baker; Beau Reilly; Joshua M Akey; Elhanan Borenstein; Mark J Rieder; Deborah A Nickerson; Raphael Bernier; Jay Shendure; Evan E Eichler
Journal:  Nature       Date:  2012-04-04       Impact factor: 49.962

Review 10.  The Ras protein superfamily: evolutionary tree and role of conserved amino acids.

Authors:  Ana Maria Rojas; Gloria Fuentes; Antonio Rausell; Alfonso Valencia
Journal:  J Cell Biol       Date:  2012-01-23       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.